Hubtown (HUBTOWN)

FairStock Score: 10/100 — RISKY

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• Debt/equity is modest at 0.40, providing some cushion in a capital-heavy business.
• Stock trades at 1.22x book value, so there is potential downside support if the stated book is credible.
• Profit grew 6.94% and the latest quarter shows strong net profit of ₹23 Cr on sales of ₹88 Cr.
• Piotroski F-Score of 6/9 points to acceptable near-term financial health.

Concerns

• Return on equity of 4.93% and ROCE of 8.13% reflect weak capital efficiency and no clear moat.
• Sales declined 5.27%, yet the stock trades at a P/E of 23.60 and PEG of 3.40, suggesting an expensive valuation relative to growth.
• Zero dividend yield means investors earn nothing while waiting for value to emerge.
• Promoter holding of 35.02% is relatively low, and the FairStock Score of 17/100 flags significant risk.

AI Analysis

When I look at Hubtown, I see a business that tests my discipline. At ₹211.40 the stock trades at 1.22 times book value of ₹172.86. That sounds cheap, but cheapness must be measured against earning power. Hubtown earns only 4.93% on equity and 8.13% on capital employed. Those returns are below what a conservative investor should demand; a low P/B ratio cannot rescue a weak business. The balance sheet is not alarming—debt/equity is 0.40—and profit rose 6.94%, but sales fell 5.27%. In a project-driven developer, revenue decline is the first sign that the machine is slowing. The latest quarter's ₹88 Cr revenue and ₹23 Cr profit show a strong margin, but one quarter is too little evidence in a lumpy real estate cycle. A P/E of 23.60 and PEG ratio of 3.40 mean the market is pricing in steady growth that the fundamentals do not confirm. The company pays no dividend, so patient shareholders receive no compensation while waiting. Promoter holding of 35.02% is not what I like to see in an Indian realty firm; minority investors need strong alignment. There are some encouraging signs: the Piotroski F-Score of 6/9 points to acceptable financial health, and the price has fallen from ₹365.70 to ₹211.40, which builds some margin of safety. But a FairStock Score of 17/100 screams risk. Graham would say that price is what you pay and value is what you get. Here, value depends on whether the assets on the balance sheet are worth book and can generate better returns. Until I see revenue growth revive, capital efficiency improve, and a clearer catalyst, this is a cyclical quasi-asset play with high risk. I would keep it on the watchlist, not in the portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer